News & Analysis on Clinical Trial Services & Contract Research And Development
Gemphire Therapeutics tapped the Canton, MI-based contract research organization (CRO) MMS Holdings to help support a Phase IIb clinical trial of its first-in-class drug candidate, Gemcabene.
DIA 2018
Cross-industry discussion is expanding from early discovery to post-licensing challenges – as the nexus of innovation and policy improvements is rapidly changing, says DIA executive.
The US FDA has sent a warning letter to Chinese contract manufacturing organisation Foshan Jinxiong Technology, which makes over-the-counter products for children.
President Trump has condemned pharmaceutical companies, including Pfizer Inc., on social media, tweeting that they have increased list prices of prescription drugs without cause.
Novartis has instigated a voluntary recall of 470,000 packages of drugs, after a child managed to open and swallow a pill from a child-resistant product.